2024 will be a pivotal year for AI Drug Discovery (AIDD). Here are 5 Industry predictions from the industry insider perspective
Alex Zhavoronkov is the Founder and CEO of Insilico Medicine, a company specializing in artificial intelligence for drug discovery and longevity research. He writes for Forbes, covering topics such as longevity biotechnology, AI in drug discovery, and the future of healthcare. His articles provide insights into the latest scientific advancements and their potential impact on the pharmaceutical industry.